Sexual Transmission of Human T-Lymphotropic Virus Type I (HTLV-I)

Abstract

Study Objective: To study the seroprevalence of human T-lymphotropic virus type I (HTLV-I) in a sexually active population and to determine sexual behavior risk factors for infection.

Design: Cross-sectional seroprevalence study using enzyme-linked immunosorbent assay (ELISA) and Western blot. Risk-factor data were gathered by administered questionnaire and chart review.

Setting: Two urban, primary care clinics for persons with sexually transmitted diseases run by the Jamaican Ministry of Health.

Patients: Of the 2050 consecutive patients presenting with new episodes of sexually transmitted disease, 1977 patients were eligible for analysis.

Measurements and Results: Overall HTLV-I seroprevalence was 5.7%; prevalence increased with age from 1.6% (age, 14 to 19 years) to 5.1% (age, 30 years and older) in men and from 5.3% (age, 14 to 19 years) to 14.1% (age, 30 years and older) in women. Compared with a reference cohort of food service employees, age-adjusted HTLV-I seroprevalence was increased in female patients with sexually transmitted disease (odds ratio = 1.83; CI, 1.41 to 2.83) but not in male patients with sexually transmitted disease. Independent risk factors for HTLV-I infection in women included having had more than ten lifetime sexual partners (odds ratio = 3.52; CI, 1.28 to 9.69) and a current diagnosis of syphilis (odds ratio = 2.12; CI, 1.12 to 3.99). In men, a history of penile sores or ulcers (odds ratio = 2.13; CI, 1.05 to 4.33) and a current diagnosis of syphilis (odds ratio = 3.56; CI, 1.24 to 10.22) were independent risk factors for HTLV-I infection. Of 1977 patients, 5 (0.3%) had antibodies to human immunodeficiency virus type 1 (HIV-1), including 2 with HTLV-I and HIV-I coinfection.

Conclusions: We conclude that HTLV-I is transmitted from infected men to women during sexual intercourse. Our data are consistent with the lower efficiency of female-to-male sexual transmission of HTLV-I, but penile ulcers or concurrent syphilis may increase a man's risk of infection.

Article and Author Information

  • From the National Cancer Institute, Bethesda, Maryland; the Ministry of Health and the University of the West Indies, Kingston, Jamaica; and the Frederick Cancer Research Facility, Frederick, Maryland. For current author addresses, see end of text.

  • Grant Support: Supported in part by research contract number NO1-CP-31006 from the National Cancer Institute.

  • Requests for Reprints: Edward L. Murphy, MD, MPH, San Francisco General Hospital, Ward 84, 995 Potrero Avenue, San Francisco, CA 94110.

  • Current Author Addresses: Dr. Murphy: San Francisco General Hospital, Ward 84, 995 Potrero Avenue, San Francisco, CA 94110.

    Dr. Figueroa: Ministry of Health, 10 Caledonia Avenue, Kingston 5, Jamaica, West Indies.

    Dr. Gibbs: Room L421, World Health Organization, 1211 Geneva 27, Switzerland.

    Dr. Brathwaite: Comprehensive Health Centre, 55 Slipe Pen Road, Kingston 5, Jamaica, West Indies.

    Dr. Holding-Cobham: Cornwall County Health Administration, P.O. Box 472, Montego Bay, Saint James, Jamaica, West Indies.

    Dr. Waters: Frederick Cancer Research Facility, P.O. Box B, Frederick, MD 21701.

    Ms. Cranston and Dr. Hanchard: Department of Pathology, University of West Indies, Mona, Kingston 7, Jamaica, West Indies.

    Dr. Blattner: National Cancer Institute, National Institutes of Health, EPN 434, Bethesda, MD 20892.

« Previous | Next Article »Table of Contents